Pulse Oximetry_Performance During Severe Signal Interference - PCBA-1 (Printed Circuit Board Assembly)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years to 50 Years (Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Healthy Well perfused
Male or female subjects between the ages of 18 to 50 years (inclusive).
Must undergo a physical examination by a licensed physician, advanced practice nurse or physician assistant, including a 12 lead ECG, a medical history, and a blood test checking complete blood count and screening for sickle cell trait or disease
All female volunteers must have a negative urine pregnancy test prior to participation.
A room-air baseline % modulation < 1.5% on all four fingers on the test hand
Pregnancy or lactating women
History of syncopal episodes
Hypertension (defined as a systolic pressure of >145 mmHg or a diastolic pressure >90 mm Hg on three consecutive readings)
Premature ventricular contractions (PVC's) that are symptomatic or occur at a rate of more than 5/minute
History of seizures (except childhood febrile seizures) or epilepsy
Routine use of tranquilizers and/or excessive anxiety
History of frequent headaches or migraines
History of stroke
Previous injury or trauma to fingers or hands that may change blood flow or vascular supply and affect our ability to test multiple sensors
History of "altitude sickness" defined as headaches, malaise or dizziness when in the mountains or in an aircraft at altitude significantly above sea level for a prolonged period of time (> 1 hour)
History of significant respiratory disease, such as severe asthma, emphysema, etc.
Sickle cell disease or trait.
The use of medications, pre-existing medical conditions, treatment for a medical condition or any other reason deemed relevant by the clinician conducting the study.
A clinically significant abnormal finding on medical history, physical examination, clinical laboratory test or ECG. Clinical significance will be assessed by the principal investigator or designee.
Prior or known allergies to lidocaine (or similar pharmacologic agents, e.g., Novocain)
Prior or known allergies to heparin
History of transient ischemic attacks or carotid artery disease
History of myocardial ischemia, angina, myocardial infarction, congestive heart failure or cardiomyopathy
History of chronic renal impairment
History of recent arterial cannulation (less than 1 month prior to study)
History of complications from previous arterial cannulation